Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
2.130
-0.120 (-5.33%)
May 21, 2025, 1:07 PM - Market open
Armata Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 11.69 | 9.29 | 13.52 | 14.85 | 10.29 | 9.65 | Upgrade
|
| Cash & Short-Term Investments | 11.69 | 9.29 | 13.52 | 14.85 | 10.29 | 9.65 | Upgrade
|
| Cash Growth | -69.13% | -31.30% | -8.95% | 44.36% | 6.62% | 59.94% | Upgrade
|
| Other Receivables | 0.24 | 0.74 | 3.36 | 8.53 | 2.99 | 0.56 | Upgrade
|
| Receivables | 0.24 | 0.74 | 3.36 | 8.53 | 2.99 | 0.56 | Upgrade
|
| Prepaid Expenses | 1.24 | 1.27 | 2.27 | 3.66 | 1.72 | 0.64 | Upgrade
|
| Total Current Assets | 13.17 | 11.31 | 19.15 | 27.05 | 15 | 10.85 | Upgrade
|
| Property, Plant & Equipment | 53.97 | 54.93 | 57.28 | 46.65 | 38.07 | 12.84 | Upgrade
|
| Goodwill | - | 3.49 | 3.49 | 3.49 | 3.49 | 3.49 | Upgrade
|
| Long-Term Deferred Charges | - | 10.26 | 10.26 | 10.26 | 10.26 | 10.26 | Upgrade
|
| Other Long-Term Assets | 6.37 | 6.46 | 8.19 | 8.39 | 2.96 | 2.09 | Upgrade
|
| Total Assets | 87.25 | 86.44 | 98.36 | 95.83 | 69.77 | 39.52 | Upgrade
|
| Accounts Payable | 7.76 | 0.77 | 1.59 | 1.68 | 1.14 | 0.96 | Upgrade
|
| Accrued Expenses | - | 3.57 | 4.87 | 6.18 | 2.17 | 1.54 | Upgrade
|
| Short-Term Debt | 27.69 | - | - | - | - | 0.72 | Upgrade
|
| Current Portion of Long-Term Debt | 75.09 | 38.95 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | 4.43 | 9.48 | 17.01 | 1.51 | 1.55 | Upgrade
|
| Other Current Liabilities | - | 0.53 | 0.52 | - | - | 1.94 | Upgrade
|
| Total Current Liabilities | 110.54 | 48.25 | 16.46 | 24.87 | 4.81 | 6.71 | Upgrade
|
| Long-Term Debt | - | 55.44 | 82.31 | - | - | - | Upgrade
|
| Long-Term Leases | 27.42 | 27.69 | 28.58 | 31.8 | 36.48 | 10.88 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | Upgrade
|
| Total Liabilities | 141.03 | 134.46 | 130.43 | 59.75 | 44.37 | 20.66 | Upgrade
|
| Common Stock | -53.78 | 0.36 | 0.36 | 0.36 | 0.27 | 0.19 | Upgrade
|
| Additional Paid-In Capital | - | 279.35 | 276.39 | 275.49 | 227.98 | 198.37 | Upgrade
|
| Retained Earnings | - | -327.74 | -308.82 | -239.77 | -202.86 | -179.7 | Upgrade
|
| Shareholders' Equity | -53.78 | -48.02 | -32.07 | 36.08 | 25.4 | 18.86 | Upgrade
|
| Total Liabilities & Equity | 87.25 | 86.44 | 98.36 | 95.83 | 69.77 | 39.52 | Upgrade
|
| Total Debt | 130.2 | 126.52 | 120.37 | 48.82 | 37.99 | 13.15 | Upgrade
|
| Net Cash (Debt) | -118.51 | -117.22 | -106.85 | -33.96 | -27.7 | -3.5 | Upgrade
|
| Net Cash Per Share | -3.28 | -1.98 | -2.96 | -0.99 | -1.15 | -0.21 | Upgrade
|
| Filing Date Shares Outstanding | 36.2 | 36.18 | 36.15 | 36.14 | 30.73 | 24.94 | Upgrade
|
| Total Common Shares Outstanding | 36.2 | 36.18 | 36.12 | 36.14 | 27.11 | 18.69 | Upgrade
|
| Working Capital | -97.37 | -36.94 | 2.69 | 2.17 | 10.18 | 4.14 | Upgrade
|
| Book Value Per Share | -1.49 | -1.33 | -0.89 | 1.00 | 0.94 | 1.01 | Upgrade
|
| Tangible Book Value | -67.53 | -51.51 | -35.56 | 32.59 | 21.91 | 15.37 | Upgrade
|
| Tangible Book Value Per Share | -1.87 | -1.42 | -0.98 | 0.90 | 0.81 | 0.82 | Upgrade
|
| Machinery | - | 14.29 | 12.83 | 11.27 | 9.02 | 7.68 | Upgrade
|
| Construction In Progress | - | 8.3 | 8.1 | - | - | - | Upgrade
|
| Leasehold Improvements | - | 3.8 | 3.45 | 3.45 | 3.42 | 3.42 | Upgrade
|
Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.